Poor correlation between body surface area and glomerular filtration rate

Cancer Chemotherapy and Pharmacology

Volumn 46, Issue 6, 2000, Pages 523-526

  Dooley, Michael Joseph ^a   Poole, Susan Gaye ^a  

^a PETER MACCALLUM CANCER CENTRE   (Australia)

Author keywords

Actual body weight; Body surface area; Clearance; DTPA; Glomerular filtration rate; Ideal body weight

Indexed keywords

PENTETATE TECHNETIUM TC 99M;

ADULT; AGED; ANALYTIC METHOD; ARTICLE; BODY HEIGHT; BODY SURFACE; BODY WEIGHT; CONTROLLED STUDY; CORRELATION FUNCTION; DIAGNOSTIC VALUE; DRUG CLEARANCE; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; STATISTICAL ANALYSIS;

ADULT; AGED; AGED, 80 AND OVER; BODY SURFACE AREA; BODY WEIGHT; CONFIDENCE INTERVALS; GLOMERULAR FILTRATION RATE; HUMANS; LINEAR MODELS; MIDDLE AGED; RADIOPHARMACEUTICALS; TECHNETIUM TC 99M PENTETATE;

EID: 0033660249     PISSN: 03445704     EISSN: None     Source Type: Journal    
DOI: 10.1007/PL00006751     Document Type: Article

References (26)

1. The use of surface area for establishing normal blood volume
2. A comparison between estimates of GFR using [99m]TcDTPA clearance and approximation of Cockcroft and Gault
3. A formula to estimate the approximate surface area if height and weight be known
4. Comparative assessment of the techniques for estimation of glomerular filtration rate with (99m)Tc-DTPA
5. Comparison of radionucleotide estimation of glomerular filtration rate using technetium 99m diethylenetriaminepentaacetic acid and chromium 51 ethylenediaminetetraacetic acid
6. Estimation of human body surface area from height and weight
7. Actual versus ideal weight in the calculation of surface area. Effect on dose of 11 chemotherapy agents
8. Is dose normalization to weight or body surface area useful in adults
9. Dose calculation of anticancer drugs: A review of the current practice and introduction of an alternative
10. Factors affecting epirubicin pharmacokinetics and toxicity: Evidence against using body-surface area for dose calculation
11. Should clearance be normalised to body surface or to lean body mass?
12. Studies on urea excretion: The influence of body size on urea output
13. The correct physiological basis on which to compare infant and adult renal function
14. Carboplatin dosing based on measurement of renal function - Experience at the Peter MacCallum Cancer Institute
15. Lean body mass as a predictor of drug dosage. Implications for drug therapy
16. Relationships among liver and kidney volumes, lean body mass and drug clearance
17. Quantification of renal haemodynamics with radionucleotides
18. The use of body surface area as a criterion of drug dosage in cancer chemotherapy
19. Simultaneous measurement of Tc-99mDTPA, Cr-51 EDTA and inulin in man
20. Normalization of anti-cancer drug dosage using bodyweight and surface area. Is it worthwhile? A review of theoretical and practical considerations
21. Nomogram for determination of human body surface area from height and weight
22. Limitations of creatinine as a filtration marker in glomerulopathic patients
23. Estimating creatinine clearance in elderly patients with low serum creatinine concentrations
24. Fallacy of indexing renal and systemic hemodynamic measurements for body surface area